tiprankstipranks
CytomX upgraded on pancreatic cancer data at Piper Sandler
PremiumThe FlyCytomX upgraded on pancreatic cancer data at Piper Sandler
2M ago
CytomX Therapeutics upgraded to Overweight from Neutral at Piper Sandler
PremiumThe Fly
CytomX Therapeutics upgraded to Overweight from Neutral at Piper Sandler
2M ago
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
PremiumPress Releases
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
2M ago
CytomX Therapeutics upgraded to Outperform from Neutral at Wedbush
PremiumThe FlyCytomX Therapeutics upgraded to Outperform from Neutral at Wedbush
2M ago
CytomX Therapeutics announces initial data from CX-904 trial
PremiumThe Fly
CytomX Therapeutics announces initial data from CX-904 trial
2M ago
CytomX Therapeutics reports Q1 EPS 17c, consensus (8c)
PremiumThe Fly
CytomX Therapeutics reports Q1 EPS 17c, consensus (8c)
2M ago
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)
PremiumPress ReleasesCytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)
2M ago
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
PremiumThe Fly
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100